HER-2/c-erbB-2/neu/CD340 Recombinant Monoclonal Antibody for IHC (P) ErbB2 (HER2) is a receptor tyrosine kinase that is overexpressed in some breast tumors. Herceptin, used in treatment of metastatic Her2-positive cancer, is monoclonal antibody targeting
HER-2/c-erbB-2/neu/CD340 Recombinant Monoclonal Antibody for IHC (P) ErbB2 (HER2) is a receptor tyrosine kinase that is overexpressed in some breast tumors. Herceptin, used in treatment of metastatic Her2-positive cancer, is monoclonal antibody targeting
Read more ...